CAR T-cell therapy bolstered by stiffening up cancer cells first

AI Insight

CAR T-cell therapy, a form of immunotherapy that engineers patients' own immune cells to target cancer, may become more effective when cancer cells are physically stiffened prior to treatment. Research suggests that altering the mechanical properties of tumour cells enhances the ability of CAR T-cells to recognize and destroy them. This approach represents a combination strategy that leverages biophysical manipulation alongside existing cellular immunotherapy techniques.

Why it matters

If validated in clinical settings, this method could improve outcomes for patients with cancers that currently show partial or limited responses to CAR T-cell therapy, potentially broadening the range of treatable tumour types.